What are the Recommendations for Placement/Removal of Epidural Catheters in Patients Receiving Concurrent Thromboprophylaxis? - NeLM

Homepage

Login | Register

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

What are the Recommendations for Placement/Removal of Epidural Catheters in Patients Receiving Concurrent Thromboprophylaxis?

Publisher: UK Clinical Pharmacy Association

Date published: 04/01/2011 10:00

Review date: 30/04/2012 11:30

Summary

by: UK Clinical Pharmacy Association

The risks to the patient posed by thromboprophylaxis therapy while receiving or discontinuing epidural medication are reviewed, and various methods to reduce risk highlighted.

About this library entry

Category: 2.8 Anticoagulants and protamine | Venous Thromboembolism

NeLM area: Evidence > Medicines Q & A

QA328_2Epidural_catheters_thromboprophylaxis.doc

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.

Printer Friendly Version

Related evidence

2.8 Anticoagulants and protamine

27/01/2012

A briefing paper on dabigatran and rivaroxaban

25/01/2012

NICE issues final guidance on apixaban for the prevention of VTE after total hip or knee replacement in adults

12/12/2011

SMC accepts apixaban (Eliquis®) for VTE prevention following orthopaedic surgery

Venous Thromboembolism

25/01/2012

NICE issues final guidance on apixaban for the prevention of VTE after total hip or knee replacement in adults

12/12/2011

SMC accepts apixaban (Eliquis®) for VTE prevention following orthopaedic surgery

13/09/2011

SMC accepts dabigatran (Pradaxa®) for prevention of stroke and systemic embolism in AF

Back